Selected research
Industry Research
Pharmaceuticals and Excipients Industry Research Report 2026
Market perspective
The global Pharmaceuticals and Excipients market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Pharmaceuticals and Excipients is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Pharmaceuticals and Excipients is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Pharmaceuticals and Excipients is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Pharmaceuticals and Excipients include Signet Chemical Corporation, Sigachi Industries, Shin-Etsu, Roquette, MEGGLE AG, Lubrizol, JRS Pharma, Evonik and ER-KANG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Pharmaceuticals and Excipients market in terms of revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pharmaceuticals and Excipients Market by Company
Signet Chemical Corporation
Sigachi Industries
Shin-Etsu
Roquette
MEGGLE AG
Lubrizol
JRS Pharma
Evonik
ER-KANG
Dow
BASF
Ashland
ABITEC Corp
Pharmaceuticals and Excipients Segment by Type
Starch
Mannitol
Triglycerides
Dextrose
Sorbitol
Sucrose
Others
Pharmaceuticals and Excipients Segment by Application
Parenteral Formulations
Topical Formulations
Oral Formulations
Other
Pharmaceuticals and Excipients Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceuticals and Excipients market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmaceuticals and Excipients and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceuticals and Excipients.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Pharmaceuticals and Excipients manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Pharmaceuticals and Excipients by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Pharmaceuticals and Excipients in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Starch
- Mannitol
- Triglycerides
- Dextrose
- Sorbitol
- Sucrose
- Others
Applications
- Parenteral Formulations
- Topical Formulations
- Oral Formulations
- Other
Companies covered
- Signet Chemical Corporation
- Sigachi Industries
- Shin-Etsu
- Roquette
- MEGGLE AG
- Lubrizol
- JRS Pharma
- Evonik
- ER-KANG
- Dow
- BASF
- Ashland
- ABITEC Corp
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Pharmaceuticals and Excipients Market Size (2021-2032)
- 2.2.2 Global Pharmaceuticals and Excipients Sales (2021-2032)
- 2.2.3 Global Pharmaceuticals and Excipients Market Average Price (2021-2032)
- 2.3 Pharmaceuticals and Excipients by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Starch
- 2.3.3 Mannitol
- 2.3.4 Triglycerides
- 2.3.5 Dextrose
- 2.3.6 Sorbitol
- 2.3.7 Sucrose
- 2.3.8 Others
- 2.4 Pharmaceuticals and Excipients by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Parenteral Formulations
- 2.4.3 Topical Formulations
- 2.4.4 Oral Formulations
- 2.4.5 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Pharmaceuticals and Excipients Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Pharmaceuticals and Excipients Sales (Tons) of Manufacturers (2021-2026)
- 3.3 Global Pharmaceuticals and Excipients Revenue of Manufacturers (2021-2026)
- 3.4 Global Pharmaceuticals and Excipients Average Price by Manufacturers (2021-2026)
- 3.5 Global Pharmaceuticals and Excipients Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Pharmaceuticals and Excipients, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Pharmaceuticals and Excipients, Product Type & Application
- 3.8 Global Manufacturers of Pharmaceuticals and Excipients, Established Date
- 3.9 Global Pharmaceuticals and Excipients Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Signet Chemical Corporation
- 4.1.1 Signet Chemical Corporation Company Information
- 4.1.2 Signet Chemical Corporation Business Overview
- 4.1.3 Signet Chemical Corporation Pharmaceuticals and Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Signet Chemical Corporation Pharmaceuticals and Excipients Product Portfolio
- 4.1.5 Signet Chemical Corporation Recent Developments
- 4.2 Sigachi Industries
- 4.2.1 Sigachi Industries Company Information
- 4.2.2 Sigachi Industries Business Overview
- 4.2.3 Sigachi Industries Pharmaceuticals and Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sigachi Industries Pharmaceuticals and Excipients Product Portfolio
- 4.2.5 Sigachi Industries Recent Developments
- 4.3 Shin-Etsu
- 4.3.1 Shin-Etsu Company Information
- 4.3.2 Shin-Etsu Business Overview
- 4.3.3 Shin-Etsu Pharmaceuticals and Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Shin-Etsu Pharmaceuticals and Excipients Product Portfolio
- 4.3.5 Shin-Etsu Recent Developments
- 4.4 Roquette
- 4.4.1 Roquette Company Information
- 4.4.2 Roquette Business Overview
- 4.4.3 Roquette Pharmaceuticals and Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Roquette Pharmaceuticals and Excipients Product Portfolio
- 4.4.5 Roquette Recent Developments
- 4.5 MEGGLE AG
- 4.5.1 MEGGLE AG Company Information
- 4.5.2 MEGGLE AG Business Overview
- 4.5.3 MEGGLE AG Pharmaceuticals and Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 MEGGLE AG Pharmaceuticals and Excipients Product Portfolio
- 4.5.5 MEGGLE AG Recent Developments
- 4.6 Lubrizol
- 4.6.1 Lubrizol Company Information
- 4.6.2 Lubrizol Business Overview
- 4.6.3 Lubrizol Pharmaceuticals and Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Lubrizol Pharmaceuticals and Excipients Product Portfolio
- 4.6.5 Lubrizol Recent Developments
- 4.7 JRS Pharma
- 4.7.1 JRS Pharma Company Information
- 4.7.2 JRS Pharma Business Overview
- 4.7.3 JRS Pharma Pharmaceuticals and Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 JRS Pharma Pharmaceuticals and Excipients Product Portfolio
- 4.7.5 JRS Pharma Recent Developments
- 4.8 Evonik
- 4.8.1 Evonik Company Information
- 4.8.2 Evonik Business Overview
- 4.8.3 Evonik Pharmaceuticals and Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Evonik Pharmaceuticals and Excipients Product Portfolio
- 4.8.5 Evonik Recent Developments
- 4.9 ER-KANG
- 4.9.1 ER-KANG Company Information
- 4.9.2 ER-KANG Business Overview
- 4.9.3 ER-KANG Pharmaceuticals and Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 ER-KANG Pharmaceuticals and Excipients Product Portfolio
- 4.9.5 ER-KANG Recent Developments
- 4.10 Dow
- 4.10.1 Dow Company Information
- 4.10.2 Dow Business Overview
- 4.10.3 Dow Pharmaceuticals and Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Dow Pharmaceuticals and Excipients Product Portfolio
- 4.10.5 Dow Recent Developments
- 4.11 BASF
- 4.11.1 BASF Company Information
- 4.11.2 BASF Business Overview
- 4.11.3 BASF Pharmaceuticals and Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 BASF Pharmaceuticals and Excipients Product Portfolio
- 4.11.5 BASF Recent Developments
- 4.12 Ashland
- 4.12.1 Ashland Company Information
- 4.12.2 Ashland Business Overview
- 4.12.3 Ashland Pharmaceuticals and Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Ashland Pharmaceuticals and Excipients Product Portfolio
- 4.12.5 Ashland Recent Developments
- 4.13 ABITEC Corp
- 4.13.1 ABITEC Corp Company Information
- 4.13.2 ABITEC Corp Business Overview
- 4.13.3 ABITEC Corp Pharmaceuticals and Excipients Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 ABITEC Corp Pharmaceuticals and Excipients Product Portfolio
- 4.13.5 ABITEC Corp Recent Developments
5 Global Pharmaceuticals and Excipients Market Scenario by Region
- 5.1 Global Pharmaceuticals and Excipients Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Pharmaceuticals and Excipients Sales by Region: 2021-2032
- 5.2.1 Global Pharmaceuticals and Excipients Sales by Region: 2021-2026
- 5.2.2 Global Pharmaceuticals and Excipients Sales by Region: 2027-2032
- 5.3 Global Pharmaceuticals and Excipients Revenue by Region: 2021-2032
- 5.3.1 Global Pharmaceuticals and Excipients Revenue by Region: 2021-2026
- 5.3.2 Global Pharmaceuticals and Excipients Revenue by Region: 2027-2032
- 5.4 North America Pharmaceuticals and Excipients Market Facts & Figures by Country
- 5.4.1 North America Pharmaceuticals and Excipients Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Pharmaceuticals and Excipients Sales by Country (2021-2032)
- 5.4.3 North America Pharmaceuticals and Excipients Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Pharmaceuticals and Excipients Market Facts & Figures by Country
- 5.5.1 Europe Pharmaceuticals and Excipients Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Pharmaceuticals and Excipients Sales by Country (2021-2032)
- 5.5.3 Europe Pharmaceuticals and Excipients Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Pharmaceuticals and Excipients Market Facts & Figures by Country
- 5.6.1 Asia Pacific Pharmaceuticals and Excipients Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Pharmaceuticals and Excipients Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Pharmaceuticals and Excipients Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Pharmaceuticals and Excipients Market Facts & Figures by Country
- 5.7.1 South America Pharmaceuticals and Excipients Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Pharmaceuticals and Excipients Sales by Country (2021-2032)
- 5.7.3 South America Pharmaceuticals and Excipients Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Pharmaceuticals and Excipients Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Pharmaceuticals and Excipients Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Pharmaceuticals and Excipients Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Pharmaceuticals and Excipients Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Pharmaceuticals and Excipients Sales by Type (2021-2032)
- 6.1.1 Global Pharmaceuticals and Excipients Sales by Type (2021-2032) & (Tons)
- 6.1.2 Global Pharmaceuticals and Excipients Sales Market Share by Type (2021-2032)
- 6.2 Global Pharmaceuticals and Excipients Revenue by Type (2021-2032)
- 6.2.1 Global Pharmaceuticals and Excipients Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Pharmaceuticals and Excipients Revenue Market Share by Type (2021-2032)
- 6.3 Global Pharmaceuticals and Excipients Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Pharmaceuticals and Excipients Sales by Application (2021-2032)
- 7.1.1 Global Pharmaceuticals and Excipients Sales by Application (2021-2032) & (Tons)
- 7.1.2 Global Pharmaceuticals and Excipients Sales Market Share by Application (2021-2032)
- 7.2 Global Pharmaceuticals and Excipients Revenue by Application (2021-2032)
- 7.2.1 Global Pharmaceuticals and Excipients Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Pharmaceuticals and Excipients Revenue Market Share by Application (2021-2032)
- 7.3 Global Pharmaceuticals and Excipients Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Pharmaceuticals and Excipients Value Chain Analysis
- 8.1.1 Pharmaceuticals and Excipients Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Pharmaceuticals and Excipients Production Mode & Process
- 8.2 Pharmaceuticals and Excipients Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Pharmaceuticals and Excipients Distributors
- 8.2.3 Pharmaceuticals and Excipients Customers
9 Global Pharmaceuticals and Excipients Analyzing Market Dynamics
- 9.1 Pharmaceuticals and Excipients Industry Trends
- 9.2 Pharmaceuticals and Excipients Industry Drivers
- 9.3 Pharmaceuticals and Excipients Industry Opportunities and Challenges
- 9.4 Pharmaceuticals and Excipients Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst